FR362M - New drug for the treatment of staphylococcal infections and salmonellosis. - Google Patents

New drug for the treatment of staphylococcal infections and salmonellosis.

Info

Publication number
FR362M
FR362M FR837020A FR837020A FR362M FR 362 M FR362 M FR 362M FR 837020 A FR837020 A FR 837020A FR 837020 A FR837020 A FR 837020A FR 362 M FR362 M FR 362M
Authority
FR
France
Prior art keywords
salmonellosis
treatment
new drug
staphylococcal infections
staphylococcal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR837020A
Other languages
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Chilcott Pharmaceuticals Inc
Original Assignee
Norwich Pharmacal Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR797625A external-priority patent/FR1271032A/en
Application filed by Norwich Pharmacal Co filed Critical Norwich Pharmacal Co
Priority to FR837020A priority Critical patent/FR362M/en
Application granted granted Critical
Publication of FR362M publication Critical patent/FR362M/en
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
FR837020A 1958-06-19 1960-08-29 New drug for the treatment of staphylococcal infections and salmonellosis. Active FR362M (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR837020A FR362M (en) 1958-06-19 1960-08-29 New drug for the treatment of staphylococcal infections and salmonellosis.

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US742985A US2920074A (en) 1958-06-19 1958-06-19 1-(5-nitrofurfurylideneamino)-2-imidazolidinethione
FR797625A FR1271032A (en) 1958-06-19 1959-06-16 1- (5-nitrofurfurylidèneamino) -2-imidazolidine-thione and process for preparing this compound
FR837020A FR362M (en) 1958-06-19 1960-08-29 New drug for the treatment of staphylococcal infections and salmonellosis.

Publications (1)

Publication Number Publication Date
FR362M true FR362M (en) 1961-04-04

Family

ID=24987053

Family Applications (1)

Application Number Title Priority Date Filing Date
FR837020A Active FR362M (en) 1958-06-19 1960-08-29 New drug for the treatment of staphylococcal infections and salmonellosis.

Country Status (7)

Country Link
US (1) US2920074A (en)
BE (1) BE579709A (en)
CH (1) CH376121A (en)
DE (1) DE1092021B (en)
FR (1) FR362M (en)
GB (1) GB850006A (en)
NL (1) NL108055C (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3041334A (en) * 1959-10-23 1962-06-26 Norwich Pharma Co 1-[3-(5-nitro-2-furyl)-2-propen-1-ylideneamino]-2-imidazolidinethione
US3115499A (en) * 1959-10-23 1963-12-24 Norwich Pharma Co 1-(2-hydroxyethyl)-3-amino-2-imidazolidine-thione
NL286389A (en) * 1961-12-06
US3076805A (en) * 1962-02-26 1963-02-05 Norwich Pharma Co New 1-(hydroxy(lower) alkyl)-3-(5-nitrofurfurylideneamino)-2-imidazolidinethiones
US3254075A (en) * 1963-08-28 1966-05-31 Norwich Pharma Co 1-(2-hydroxyethyl and 2-haloethyl-3-(5-nitrofurfurylideneamino)-2-imidazolidinones
US3397199A (en) * 1964-12-02 1968-08-13 Smith Kline French Lab Nitrothenylideneamino compounds
US4105850A (en) * 1977-05-13 1978-08-08 Morton-Norwich Products, Inc. 1-Amino-3-(4-chlorophenyl)-2-imidazolidinone
HU199443B (en) * 1984-06-25 1990-02-28 Chinoin Gyogyszer Es Vegyeszet Bactericidal and/or fungicidal synergic plant protective comprising nitrofuran derivatives

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE515245A (en) * 1950-05-29
DE1005970B (en) * 1953-08-10 1957-04-11 Norwich Pharma Co Process for the production of new hydrazones of the 5-nitrofuran series
US2746960A (en) * 1955-05-26 1956-05-22 Norwith Pharmacal Company New chemotherapeutic nitrofurans
US2776979A (en) * 1956-04-05 1957-01-08 Norwich Pharma Co 1-nitroso-2-imidazolidone and process

Also Published As

Publication number Publication date
GB850006A (en) 1960-09-28
US2920074A (en) 1960-01-05
BE579709A (en) 1959-10-01
DE1092021B (en) 1960-11-03
NL108055C (en)
CH376121A (en) 1964-03-31

Similar Documents

Publication Publication Date Title
FR1444M (en) New drug especially for the treatment of ovarian irregularities and insufficiencies.
FR1225547A (en) Device for drug treatment of teeth
FR362M (en) New drug for the treatment of staphylococcal infections and salmonellosis.
FR2609M (en) New drug for the treatment of staphylococcal and streptococcal infections.
BE582173A (en) Advanced device for the treatment of threads.
FR365M (en) New drug for the treatment of staphylococcal and streptococcal infections.
FR363M (en) New drug for the treatment of trypanosomosis, salmonellosis and penicillofacial infections.
FR126M (en) New drug, in particular for the treatment of postprandial or chronic hyperlipemia.
FR2510M (en) New medicament usable for the treatment of staphylococcal infections and the like.
FR385M (en) New drug for the treatment of staphylococcal infections and the like.
FR364M (en) New drug for the treatment of salmonellosis, staphylococcal disease and trichomonosis.
FR2193M (en) New drug for the treatment of infectious diseases.
FR33F (en) New drug for the treatment of staphylococcal infections and the like.
FR2802M (en) New drug especially for the treatment of ovarian irregularities and insufficiencies.
FR3875M (en) New drug particularly suitable for the treatment of tuberculosis infections.
FR3187M (en) New drug in particular for the treatment of irregularities and ovarian insufficiencies.
FR1172M (en) New drug especially for the treatment of ovarian irregularities and insufficiencies.
FR2413M (en) New drug, in particular for the treatment of inflammatory and painful manifestations.
FR2929M (en) Pharmaceutical composition for the treatment of arthritic and rheumatic conditions.
FR151M (en) New drug, in particular for the treatment of neuro-depressive states and anxiety psychoses.
FR1729M (en) New drug, in particular for the treatment of inflammatory and painful manifestations.
FR23F (en) New drug in particular for the treatment of infections due to staphylococci.
FR1259M (en) New drug in particular for the treatment of infections due to staphylococci.
FR1217913A (en) Device for the treatment of certain microbial diseases
BE630069A (en) Therapeutic composition for the treatment of parkinsonism.